Alamar Biosciences Secures Oversubscribed Funding and Expands Leadership
January 12, 2026 | 11:43
The biotech firm Alamar Biosciences has successfully closed an oversubscribed convertible notes round while strengthening its executive team for future growth.
Mobile Version